Clinical trial
Impact of Liraglutide on Endothelial Function and Microvascular Blood Flow in Type 2 Diabetes Mellitus
NCT01208012 is registered in ClinicalTrials.gov with ikfe-CRO GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Liraglutide on Endothelial Function and Microvascular Blood Flow in Type 2 Diabetes Mellitus
- Lead sponsor
- ikfe-CRO GmbH
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 30, 2010
- Completion date
- November 30, 2010
- Enrollment
- 44 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.